124 related articles for article (PubMed ID: 37203893)
21. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
[TBL] [Abstract][Full Text] [Related]
22. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
[No Abstract] [Full Text] [Related]
23. Positive Bacterial Culture among Adults with Suspected Urinary Tract Infections Presenting to the Department of Medicine of a Tertiary Care Centre.
Jwarchan B; Sapkota S; Dhungana D; Dhakal A
JNMA J Nepal Med Assoc; 2024 Feb; 62(270):89-91. PubMed ID: 38409980
[TBL] [Abstract][Full Text] [Related]
24. High Prevalence of Multidrug-Resistant Escherichia coli in Urine Samples from Inpatients and Outpatients at a Tertiary Care Hospital in Sétif, Algeria.
Nabti LZ; Sahli F; Radji N; Mezaghcha W; Semara L; Aberkane S; Lounnas M; Solassol J; Didelot MN; Jean-Pierre H; Dumont Y; Godreuil S
Microb Drug Resist; 2019 Apr; 25(3):386-393. PubMed ID: 30676258
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
[TBL] [Abstract][Full Text] [Related]
26. Extended-spectrum beta-lactamases and plasmid diversity in urinary isolates of Escherichia coli in Croatia: a nation-wide, multicentric, retrospective study.
Krilanović M; Tomić-Paradžik M; Meštrović T; Beader N; Herljević Z; Conzemius R; Barišić I; Vraneš J; Elveđi-Gašparović V; Bedenić B
Folia Microbiol (Praha); 2020 Aug; 65(4):649-667. PubMed ID: 31953747
[TBL] [Abstract][Full Text] [Related]
27. [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
Blanco VM; Maya JJ; Correa A; Perenguez M; Muñoz JS; Motoa G; Pallares CJ; Rosso F; Matta L; Celis Y; Garzon M; Villegas MV
Enferm Infecc Microbiol Clin; 2016 Nov; 34(9):559-565. PubMed ID: 26774256
[TBL] [Abstract][Full Text] [Related]
28. Biofilm Formation and Extended-Spectrum Beta-Lactamase Producer among Acinetobacter Species Isolated in a Tertiary Care Hospital: A Descriptive Cross-sectional Study.
Sharma M; Sapkota J; Jha B; Mishra B; Bhatt CP
JNMA J Nepal Med Assoc; 2019; 57(220):424-428. PubMed ID: 32335654
[TBL] [Abstract][Full Text] [Related]
29. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020).
Arends SJR; Butler D; Scangarella-Oman N; Castanheira M; Mendes RE
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0152522. PubMed ID: 36877017
[TBL] [Abstract][Full Text] [Related]
31. [Resistant phenotypes of Escherichia coli strains responsible for urinary tract infection in the laboratory of the University Hospital Joseph Raseta Befelatanana, Antananarivo].
Rakotovao-Ravahatra ZD; Randriatsarafara FM; Rasoanandrasana S; Raverohanta L; Rakotovao AL
Pan Afr Med J; 2017; 26():166. PubMed ID: 28674559
[TBL] [Abstract][Full Text] [Related]
32. [Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a Level III Hospital - A Retrospective Study].
Simões A; Lima M; Brett A; Queiroz C; Chaves C; Oliveira H; Januário L; Rodrigues F
Acta Med Port; 2020 Jul; 33(7-8):466-474. PubMed ID: 31962058
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Class 1 Integrons and Extended Spectrum Beta Lactamases among Multi-Drug Resistant Escherichia coli Isolates from North of Iran.
Mehdipour Moghaddam MJ; Mirbagheri AA; Salehi Z; Habibzade SM
Iran Biomed J; 2015; 19(4):233-9. PubMed ID: 26220727
[TBL] [Abstract][Full Text] [Related]
34. ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.
Magale HI; Kassim IA; Odera SA; Omolo MJ; Jaoko WG; Jolly PE
East Afr Med J; 2015 Jul; 92(7):333-337. PubMed ID: 27867208
[TBL] [Abstract][Full Text] [Related]
35. Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
Auer S; Wojna A; Hell M
Antimicrob Agents Chemother; 2010 Sep; 54(9):4006-8. PubMed ID: 20585127
[TBL] [Abstract][Full Text] [Related]
36. Extended-spectrum β-lactamase producing E. coli in urinary tract infections: A two-center, cross-sectional study of prevalence, genotypes and risk factors in Amman, Jordan.
Al-Jamei SA; Albsoul AY; Bakri FG; Al-Bakri AG
J Infect Public Health; 2019; 12(1):21-25. PubMed ID: 30145152
[TBL] [Abstract][Full Text] [Related]
37. Determination of epidemiology and antimicrobial susceptibility of extended spectrum beta lactamase producing uropathogens.
Iqbal R
J Pak Med Assoc; 2019 May; 69(5):690-694. PubMed ID: 31105289
[TBL] [Abstract][Full Text] [Related]
38. The prevalence and predictors of extended spectrum B-lactamase urinary tract infections among emergency department patients: A retrospective chart review.
Bou Chebl R; Assaf M; Kattouf N; Abou Arbid S; Haidar S; Geha M; Makki M; Tamim H; Abou Dagher G
Am J Emerg Med; 2021 Nov; 49():304-309. PubMed ID: 34182275
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management.
Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Scangarella-Oman NE; Yu K; Ye G; Mitrani-Gold FS
Clin Infect Dis; 2021 Dec; 73(11):1992-1999. PubMed ID: 34143881
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.
Roldan-Masedo E; Sainz T; Gutierrez-Arroyo A; Gomez-Gil RM; Ballesteros E; Escosa L; Baquero-Artigao F; Méndez-Echevarría A
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2097-2102. PubMed ID: 31359255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
